Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro

Fig. 2

Remifentanil's effects on the contractile function of ischaemic cardiomyocytes. The number of observations: 104. X axis means time of reoxygenation in minutes. Y axis means percentages of the values of contraction amplitudes obtained at the beginning of the experimental protocol. Remifentanil (5 μM or 50 μM) were used from the beginning of the reoxygenation period. Trabecula contractility was assessed as the contraction's maximal amplitude. Measurements were obtained at baseline (Time:0), during reoxygenation (at the 5th, 10th, 15th, 30th, 45th, and 60th minute), and after norepinephrine application (ne)

Back to article page